RecruitingISRCTN63917405
Clinical and cost-effectiveness of an aripiprazole and sertraline drug combination in comparison with the drug quetiapine for the treatment of Depression in bipolarity
Research studyAges 18–99United Kingdom
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 18 years to 99 years. Other eligibility criteria apply.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Cumbria Northumberland Tyne and Wear NHS Foundation Trust
- Sponsor type
- Non-profit organization
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- From 18 Years to 99 Years
- Official registry ID
- ISRCTN63917405
- Official title
Show the full official title
Clinical and cost-effectiveness of an aripiprazole and sertraline drug combination in comparison with the drug quetiapine for the treatment of Depression in bipolarity
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cumbria Northumberland Tyne and Wear NHS Foundation Trust.
Who can participate?
This study is for people with bipolarity. Listed age limits: 18 years to 99 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
